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Rheumatology Clinicians’ Perceptions of Telerheumatology Within
the Veterans Health Administration: A National Survey Study
Rachel A. Matsumoto, MS*; Bryant R. England, MD†; Ginnifer Mastarone, PhD, UXE*‡;
J. Steuart Richards, MD§; Elizabeth Chang, MD‖; Patrick R. Wood, MD¶; Jennifer L. Barton, MD***
ABSTRACT
Introduction
The Department of Veterans Affairs Veterans Health Administration (VA) Strategic Plan (Fiscal Year 2018–2024)
identified four priorities for care including easy access, timely and integrated care, accountability, and modernization,
all of which can be directly or indirectly impacted by telemedicine technologies. These strategic goals, coupled with
an anticipated rheumatology workforce shortage, has created a need for additional care delivery methods such as
clinical video telehealth application to rheumatology (ie, telerheumatology). Rheumatology clinician perceptions of
clinical usefulness telerheumatology have received limited attention in the past. The present study aimed to evaluate
rheumatologists’ perceptions of and experiences with telemedicine, generally, and telerheumatology, specifically, within
the VA.
Materials and Methods
A 38-item survey based on an existing telehealth providers’ satisfaction survey was developed by twoVA rheumatologists
with experience in telemedicine as well as a social scientist experienced in survey development and user experience
through an iterative process. Questions probed VA rheumatology clinician satisfaction with training and information
technology (IT) supports, as well as barriers to using telemedicine. Additionally, clinician perceptions of the impact and
usefulness of and appropriate clinical contexts for telerheumatology were evaluated. The survey was disseminated online
via VA REDCap to members of the VA Rheumatology Consortium (VARC) through a LISTSERV. The study protocol
was approved by the host institution IRB through expedited review. Survey responses were analyzed using descriptive
statistics.
Results
Forty-five anonymous responses (20% response rate) were collected. Of those who responded, 47% were female, 98%
were between 35 and 64 years old, 71% reported working at an academic center, and the majority was physician-
level practitioners (98%). Respondents generally considered themselves to be tech savvy (58%). Thirty-six percent of
the sample reported past experience with telemedicine, and, of those, 29% reported experience with telerheumatology
specifically. Clinicians identified the greatest barrier to effective telerheumatology as the inability to perform a physical
exam (71%) but agreed that telerheumatology is vital to increasing access to care (59%) and quality of care (40%) in the
VA. Overall, regardless of experience with telemedicine, respondents reported that telerheumatology was more helpful
for management of rheumatologic conditions rather than initial diagnosis.
Conclusions
While the majority of rheumatology clinicians did not report past experience with telerheumatology, they agreed that it
has potential to further the VAmission of improved access and quality of care. Rheumatology clinicians felt the suitability
of telerheumatology is dependent on the phase of care. As remote care technologies continue to be rapidly adopted into
clinic, clinician perceptions of and experiences with telemedicine will need to be addressed in order to maintain high-
quality and clinician- and patient-centric care within VA rheumatology.
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INTRODUCTION
In 2010, the Department of Veterans Affairs (VA) announced
transformational initiatives with the intention of bringing VA
into themodern era as a forward-looking, results-oriented, and
Veteran-focused organization (Strategic Plan FY 2010–2014).
These initiatives helped pave the way to further advance
telehealth services or technologies such as audio and video
tools used to deliver care across distance and time.1 Tele-
health technologies including asynchronous communications
(ie, electronic consults, delayed messaging, store and forward
telehealth) or synchronous communications (ie, video-based
communications, telecommunications2) have been available
to Veterans engaged in care at VA since 1994.3 However,
with the introduction of the transformational initiatives, the
VA has emphasized the expansion of synchronous real-time
video communications or telemedicine, where patients and
clinicians communicate remotely through video conferencing
technologies in real time. As a result, by fiscal year 2013,
more than 500,000 telemedicine encounters occurred in the
VA across all available clinical areas, an increase from just
over 150,000 in fiscal year 2010.3 More recently, the VA
marked a milestone by providing over 1 million telemedicine
visits in fiscal year 2018.4
In 2018, the VA identified four strategic goals: (1) easy
access and greater choices, (2) timely and integrated care,
(3) accountability and transparency, and (4) modernization
(Strategic Plan FY 2018–2024).5 These larger priorities
encompass areas such as improved access to care, reduced
wait times, and IT modernization, all of which can be
impacted by telehealth technologies. Notably, telemedicine
has been credited with the ability to improve access to
care for Veterans, particularly those in rural areas.6 In
fact, 47% of telemedicine encounters in fiscal year 2013
included rural VA patients.3 A recent rapid review found that
care received through telemedicine services was generally
equivalent to in-person clinical visits in the areas of telemental
health, telerehabilitation, teledermatology, teleconsultation,
and other areas such as nutrition management and oral
anticoagulation management.7 Moreover, patient satisfaction
with telemedicine visits in a non-VA setting is generally
high, and some patients report preferring telehealth visits
over in-person encounters.8 Despite positive perceptions and
continuous growth in clinical areas, telemedicine application
to rheumatology (ie, telerheumatology) has received limited
attention.2
Rheumatologic care is particularly important for the Vet-
eran population, as Veterans experience higher rates of arthri-
tis than the general population, and arthritis is the number
one cause of disability within the VA.9 Despite this high
prevalence and significant impact on quality of life, Veter-
ans seeking specialty care for arthritis often face barriers in
receiving rheumatologic care, such as distance to the near-
est rheumatology clinician. The majority of Veterans live
more than 40 miles from the nearest VA with rheumatology
services.10
Additionally, a significant national rheumatology work-
force shortage is predicted over the next decade,11 and
rheumatology has been highlighted as one of the top three
specialties predicted to have a shortage of clinicians within
the next 5 years in the VA.10 Telerheumatology has the
potential to surmount barriers to rheumatology care such
as geographical distance which includes concentrations
of specialists in urban areas and a national rheumatology
workforce shortage particularly impacting large swaths of
rural areas.
While the infrastructure for telemedicine exists in the VA,
telerheumatology is in its infancy, with limited study of clin-
ician perceptions of clinical usefulness. Therefore, the objec-
tive of this study was to assess rheumatology clinician per-
ceptions of, and experiences with, telemedicine generally
and telerheumatology specifically within the VA, the largest
integrated health care system in the United States.
METHODS
Participants
All members of the VA Rheumatology Consortium (VARC),
an association of rheumatology clinicians who meet biannu-
ally to discuss the state of rheumatology in the VA, were
invited to complete an electronic survey via email invitation
sent to the VARC LISTSERV. At the time of the survey invi-
tation, VARC membership totaled 224 members. The study
protocol was approved by the host institution IRB through
expedited review.
Survey Administration
VARC leadership (E.C. and J.S.R.) invited all members to
take part in a survey “on your experiences with and/or atti-
tudes towards telehealth services in rheumatology” through
an email invitation that included a link to the survey. Research
Electronic Data Capture (REDCap)12,13 hosted at Depart-
ment of Veterans Affairs VA Information Resource Center
(VIReC) was utilized for survey design and online dissemi-
nation. Respondents anonymously completed a 38-item sur-
vey, modeled after a general telehealth clinician’s satisfaction
survey.14
The survey included a previously developed measure of
clinician’s satisfaction with telehealth, a user experience
short survey, and novel questions identified by the study
team (described below). Participant demographics were
also collected. For the current survey, some questions were
adapted to be specific to telerheumatology, while others
addressed telemedicine more broadly. The rheumatology-
specific telemedicine survey assessed VA clinician satisfac-
tion with training and information technology support, as
well as barriers to using telemedicine systems. Additionally,
questions regarding perceptions of telemedicine’s impact on
care and appropriate clinical contexts for telerheumatology
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TABLE I. Characteristics of VAa Rheumatology Clinician Telerheumatology Survey Respondents (n = 45)
Characteristic N (%) or Mean (Standard Deviation)
Female 21 (47%)
Age categories
25–34 years 1 (2%)
35–44 years 9 (20%)
45–54 years 15 (33%)
55–64 years 12 (27%)
65–74 years 5 (11%)
75 years or older 3 (7%)
Practice setting
Rural clinic 1 (2%)
Critical access hospital 5 (11%)
Academic center 32 (71%)
Other 7 (16%)
Provider type
Physician-level clinician (MD, DO, MBBS, MD/PhD, etc.) 43 (96%)
Advanced practice provider (PA, NP, APRN, etc.) 2 (4%)
“I consider myself tech savvy,” proportion who reported “agree” or
“strongly agree”
26 (58%)
aDepartment of Veterans Affairs, Veterans Health Administration.
visits were included. The survey was developed through an
iterative process with input from twoVA rheumatologists with
experience in telerheumatology (P.W. and B.E.) and a social
scientist (G.M.) experienced in survey development.
SURVEY DESIGN AND MEASURES
User Satisfaction with Telemedicine
The user satisfaction survey with telemedicine developed by
Becevic and colleagues14 consisted of 18 telemedicine-related
items that ask about the ease of use of telemedicine equipment,
the quality of images and sounds, and how satisfied clinicians
are with telemedicine appointments. Questions are asked on
a 5-point Likert scaled from “strongly agree” to “strongly
disagree.”
Usability Metric for User Experience (UMUX-LITE)
The Usability Metric for User Experience LITE is a 2-
item standardized usability questionnaire.15 The measure
asks respondents to rate, on a 7-point Likert scale (strongly
disagree-strongly agree), the degree to which the telemedicine
“system’s capability meet my requirements” and “is easy to




To further assess clinicians’ perceptions of the appropriateness
of telerheumatology, a series of questions were developed
by the authors. Respondents were asked to identify partic-
ular clinical contexts in which telerheumatology would be
most useful (eg, new inpatient/outpatient consult, follow-up,
acute visit, other). Respondents were asked to indicate for
which rheumatologic conditions they felt telerheumatology
would be helpful in diagnosing or in managing. Additionally,
respondents were asked to rank three barriers to effective
telerheumatology (eg, inability to perform a physical exam,
quality of equipment, cost to provider due to loss of produc-
tivity, time commitment) from 1 (most important) to 3 (least
important). Lastly, questions specific to VA care and priorities
were included (eg, “I believe my role in providing telehealth
services is vital to VA efforts to increase access to care,” “I
believe my role in providing telehealth services is vital to VA
efforts to increase quality of care”).
Analysis
Survey responses were analyzed using descriptive statistics.
For questions related to clinician perception of the impact of
telemedicine on VA strategic goals, response categories of
“strongly agree or agree” or “disagree or strongly disagree”
were combined.
RESULTS
A total of 45 responses were received, for a response rate of
20%. The overwhelming majority of the respondents (96%,
Table I) identified as physician-level practitioners (ie, MD,
DO, MBBS, MD/PhD) and had worked in an academic center
(71%). Ninety-eight percent of clinicianswere between 35 and
64 years old (35–44 years old, 20%; 45–54 years old, 33%;
55–64 years old, 27%), the remaining clinicians were between
25 and 34 years old (2%). Nearly half of respondents identified
as female (47%), and 58% considered themselves to be “tech
savvy.”
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Telemedicine User Experience
Sixteen respondents (36%) reported being trained to use
telemedicine services including but not limited to teler-
heumatology. Of those 16, 50% reported using telemedicine
services for any specialty at least once per week. Satisfaction
with telemedicine systems in general was mixed. Forty-four
percent felt their telemedicine system is easy to use, and
53% felt “confident and at ease” when using a telemedicine
system.Approximately half of clinicians felt they had received
an appropriate amount of training in (44%) and that their
institution had adequate support for telemedicine services
(56%). In contrast, only 38% of respondents felt they could
provide high-quality rheumatology care through telemedicine
systems.
Perceptions of Telerheumatology
All respondents (n = 45), regardless of experience with
telemedicine systems, were asked to rank their top 3 perceived
barriers to telerheumatology. The majority of clinicians
(71%) ranked the inability to perform a physical exam as
the top barrier. The barrier most often ranked second most
important was phase of care (31%), followed by the type of
rheumatologic condition (ie, connective tissue disease; 16%).
Type of rheumatologic condition (16%) was also the barrier
most often ranked third most important to clinicians as well
as cost to clinician due to loss of productivity (16%). The cost
to clinic/institutions for set-up and maintenance of telehealth
technologies (4%) and time commitment (6%) were ranked
least often as barriers to effective telerheumatology. Most
clinicians agreed or strongly agreed that their role in providing
telemedicine services was “vital” to VA efforts to increase
access to care (59%), while fewer clinicians agreed or strongly
agreed that it is vital to VA efforts to improve quality of care
(40%) or to improve IT infrastructure (28%; Fig. 1). Almost
half of respondents (42%) neither agreed nor disagreed that
providing telemedicine services is best for patients, while
approximately one-third of clinicians (36%) felt that providing
telemedicine services is best for patients.
Usefulness of Telerheumatology
Clinicians overwhelming identified telerheumatology as
useful for managing, rather than diagnosing, rheumatologic
conditions (Figs 2 and 3). Gout or calcium pyrophosphate
dihydrate deposition disease (CPPD; 29%), rheumatoid
arthritis (RA; 24%), fibromyalgia (20%), and osteoarthritis
(20%) were considered the most appropriate conditions
to manage via telemedicine technologies by those who
reported experience with telerheumatology. Similarly, those
reporting no experience with telerheumatology consid-
ered gout or CPPD (44%), osteoarthritis (38%), and RA
(33%) to be conditions most appropriately managed via
telemedicine. A majority of clinicians did not consider
telerheumatology useful for the diagnosis of rheumato-
logic conditions. Conditions with the highest responses
FIGURE 1. Rheumatologist perceptions of benefits of telehealth services
for VA1 strategic goals (n = 45). 1 I believe my role in providing telehealth
services is best for patients. 2 I believe my role in providing telehealth services
is vital to VA efforts to increase access to care. 3 I believe my role in providing
telehealth services is vital to VA efforts to increase quality of care. 4 I believe
my role in providing telehealth services is vital to VA efforts to improve
IT infrastructure. While perceptions were mixed, most clinicians agreed or
strongly agreed that telemedicine was vital to VA efforts to increase access to
care (59%). Clinician feelings on whether medicine is best for patients were
less clear as nearly half of respondents neither agreed nor disagreed with the
statement (42%). Telemedicine offers the opportunity to expand care to harder
to reach populations (eg, rural Veterans), but clinician attitudes towards the
treatment modality may be a barrier to adoption. As the push to move routine
clinical care to telemedicine continues, health systems should recognize and
work to address clinician perceptions of telehealth technologies.
for usefulness of telerheumatology for diagnosing among
clinicians reporting experience with telerheumatology were
osteoarthritis (16%), fibromyalgia (16%), gout or CPPD
(11%), RA (4%), seronegative spondyloarthropathy (4%),
and Sjogren syndrome (4%). Among clinicians who did
not have experience with telerheumatology, osteoarthritis
(24%), fibromyalgia (22%), gout or CPPD (16%), and RA
(13%) were considered the rheumatologic conditions most
appropriately diagnosed through telemedicine technologies.
There were no statistically significant differences between
responses of clinicians with experience with telemedicine
compared to those without in the perceived usefulness of
telerheumatology for diagnosing or managing any of the
rheumatologic conditions (P > 0.05). Clinicians were given
the opportunity to select “other” and provide an open-
ended response to the usefulness of telerheumatology in
diagnosing and managing conditions. Some clinicians (18%),
regardless of telemedicine experience, noted that “none of
the above” conditions would be appropriate to diagnose via
telerheumatology.
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FIGURE 2. Proportion of rheumatologists who believe telerheumatology
is useful for diagnosing (n = 45). 1 Gout or calcium pyrophosphate dihy-
drate deposition disease (CPPD). 2 Rheumatoid arthritis. 3 Osteoarthritis.
4 Fibromyalgia. 5 Lupus. 6 Systemic sclerosis. 7 Seronegative spondy-
loarthropathy. 8 Sjogren syndrome. 9 Vasculitis. Most clinicians, regardless
of experience with telemedicine, did not consider telerheumatology useful in
diagnosing rheumatologic conditions. Clinicians with experience considered
telerheumatology useful in diagnosing slightly more conditions than those
without experience with telerheumatology. Health systems should consider
phase of care when adopting, implementing, and developing standard prac-
tices with telehealth systems to maintain the quality of care delivered.
DISCUSSION
The present study is the first national survey of VA rheuma-
tology clinician attitudes toward telerheumatology. Overall,
results suggest that direct experience with telemedicine is
infrequent and satisfaction with telerheumatology is subop-
timal. However, most clinicians agreed that telemedicine is
essential to increasing access to care and indicated that teler-
heumatology would be most useful for managing established
patients with a rheumatologic diagnosis. Rheumatologic con-
ditions such as osteoarthritis or fibromyalgia were viewed
as more appropriate for telehealth, whereas more complex
autoimmune conditions with heterogeneous clinical presen-
tations such as systemic lupus erythematosus were viewed
as requiring face-to-face care. The most commonly identi-
fied barriers to effective telerheumatology were the inability
to perform a physical exam, phase of care, and training of
presenters at the patient sites. The majority of respondents had
not previously used telemedicine systems.
The current findings support prior literature outside of
rheumatology that suggests clinicians consider telemedicine
technologies an acceptable way to increase access to care18
despite overall low uptake.19–21 This study confirms what has
been shown among other subspecialty clinician attitudes to
FIGURE 3. Proportion of rheumatologists who believe telerheumatology
is useful for managing (n = 45). 1 Gout or calcium pyrophosphate dihy-
drate deposition disease (CPPD). 2 Rheumatoid arthritis. 3 Osteoarthritis.
4 Fibromyalgia. 5 Lupus. 6 Systemic sclerosis. 7 Seronegative spondy-
loarthropathy. 8 Sjogren syndrome. 9 Vasculitis. Overall, clinicians consid-
ered telerheumatology more useful in managing rheumatologic conditions.
Clinicians with past experience with telerheumatology generally considered
the modality appropriate for managing more conditions than those who had no
experience with telerheumatology. Clinicians indicated that phase of care is an
important consideration when evaluating the usefulness of telerheumatology.
It is important for health systems to work closely with clinicians to identify
the most appropriate and useful way to incorporate telehealth technologies
into clinical care.
telemedicine (hepatitis C experience, rural providers, etc.).
It also underscores a need to more systematically elicit VA
rheumatology clinician experiences, attitudes, and concerns
as the field of telerheumatology grows to serve an expanding,
older population with arthritis and disability while, at the same
time, the nation faces a shortage of rheumatology clinicians.11
This need is particularly relevant to the VA as it is the largest
integrated healthcare system in the United States and is dedi-
cated to continuing and expanding care for rural Veterans who
are notoriously hard to reach. Additionally, pairing a robust,
efficient, and common-sense approach to telerheumatology
with the expansion of rheumatology knowledge and connec-
tion to primary care clinicians through the newly establish VA
Rheumatology ECHO (Extension for Community Healthcare
Outcomes) programwill provide needed support for local non-
specialist telehealth presenters and further the overarching
mission to increase access while simultaneously delivering
high-quality care in rheumatology.
This study is not without limitations, which include the
low response rate and relatively small sample size. How-
ever, it is worth noting that the response rate is compara-
ble to other clinical survey studies and nearly twice that










ed/usaa203/5891705 by Portland State U
niversity user on 01 Septem
ber 2020
Rheumatology Clinicians’Perceptions of Telerheumatology
of online surveys of clinicians.22,23 No validated surveys of
telerheumatology exist. Therefore, we adapted a previously
published instrument on telehealth for telerheumatology with
a team that included experienced rheumatologists practicing
telerheumatology and an expert in survey design. Despite
these limitations, these findings have important implications
for the adoption of telerheumatology technologies. A deeper
understanding of the barriers to effective telerheumatology
within the VA system from both clinician and patient per-
spectives will help with implementation. Specifically, as VA
telemedicine services grow to include more subspecialties,
more efforts can be made to expose and familiarize clinicians
to telehealth technologies through “hands-on” trainings. Addi-
tionally, probing clinicians’ attitudes about telerheumatology
can provide the foundation for guidelines for telemedicine
clinical visits.
This study aimed to characterize rheumatology clinician
perceptions and experiences with telemedicine technologies
and adds to the literature that supports telehealth as a
valuable care delivery method. Future studies are needed to
further assess the acceptability, feasibility, and effectiveness
of telerheumatology, especially for specific rheumatologic
conditions.
CONCLUSION
A majority of VA rheumatologists report that telerheuma-
tology is vital to increasing access to care in VA; however,
clinician respondents indicated the suitability of telerheuma-
tology is dependent on the phase of care. Most VA rheumatol-
ogy clinicians have yet to provide telerheumatology care. As
remote care technologies are increasingly adopted, continued
attention to clinician experience and readiness will need to be
addressed in order to maintain high-quality, patient-centered
care systems within VA rheumatology.
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